Literature DB >> 4397663

Peculiar immunobiology of bone marrow allografts. I. Graft rejection by irradiated responder mice.

G Cudkowicz, M Bennett.   

Abstract

Mice are capable of rejecting H-2-incompatible bone marrow grafts after a single lethal exposure to X-rays. The onset of rejection begins 18-24 hr after transplantation and is completed by 96 hr. Maturation of this type of allograft reactivity does not occur until the 22nd day of life. In adult mice, the resistance to marrow allografts can be weakened by administration of cyclophosphamide or dead cultures of Corynebacterium parvum, but not heterologous anti-thymocyte serum. Sublethal exposures to X-rays 7 or 14 days before transplantation also weaken resistance. There is considerable interstrain variation in the ability of mice to resist allografts, even when H-2 differences between hosts and donor are kept identical. Although H-2 incompatibility is a necessary prerequisite for resistance, additional genetic factors influence the outcome of marrow allografts, presumably by controlling recognition. The regulator genes are determinant specific and the alleles for resistance or responder status appear to be dominant. The responder phenotype is expressed by hemopoietic cells and not by the environment. Accordingly, resistance is conferred to otherwise susceptible mice upon transfer of bone marrow cells but not of serum. The production and differentiation of effector cells for marrow graft rejection are thymus independent. In conclusion, bone marrow allografts elicit a particular transplantation reaction, previously unknown, in irradiated mice. Peculiar features of this reaction are the lack of proliferation of host lymphoid cells, tissue specificity, thymus independence, and regulation by genetic factors which apparently do not affect the fate of other grafts.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4397663      PMCID: PMC2139037          DOI: 10.1084/jem.134.1.83

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  24 in total

1.  Cyclophosphamide-induced chimerism.

Authors:  J P Glynn; A Fefer; B L Halpern
Journal:  Cancer Res       Date:  1968-01       Impact factor: 12.701

2.  Quantitative studies on tissue transplantation immunity. 8. The effects of irradiation.

Authors:  L Brent; P Medawar
Journal:  Proc R Soc Lond B Biol Sci       Date:  1966-10-11

3.  Deficient Fe59 and I-125 deoxyuridine uptake by lympho-hemopoietic cell transplants engaged in homograft reactions.

Authors:  W E Davis; R Schofield; L J Cole
Journal:  J Cell Physiol       Date:  1968-06       Impact factor: 6.384

4.  Hemopoietic progenitor cells with limited potential for differentiation: erythropoietic function of mouse marrow "lymphocytes".

Authors:  M Bennett; G Cudkowicz
Journal:  J Cell Physiol       Date:  1968-10       Impact factor: 6.384

5.  Spontaneous delayed iso-hypersensitivity in guinea pigs.

Authors:  J R Battisto
Journal:  J Immunol       Date:  1968-10       Impact factor: 5.422

6.  Cloning of syngeneic hematopoietic cells in the spleens of mice and rats pretreated with cytotoxic drugs.

Authors:  G W Santos; M Haghshenass
Journal:  Blood       Date:  1968-10       Impact factor: 22.113

7.  Hemopoietic progenitor cells of W anemic mice studies in vivo and in vitro.

Authors:  M Bennett; G Cudkowicz; R S Foster; D Metcalf
Journal:  J Cell Physiol       Date:  1968-06       Impact factor: 6.384

8.  Inhibition of tumour growth by administration of killed corynebacterium parvum.

Authors:  B N Halpern; G Biozzi; C Stiffel; D Mouton
Journal:  Nature       Date:  1966-11-19       Impact factor: 49.962

9.  Bone marrow as a source of cells in reactions of cellular hypersensitivity. I. Passive transfer of tuberculin sensitivity in syngeneic systems.

Authors:  D M Lubaroff; B H Waksman
Journal:  J Exp Med       Date:  1968-12-01       Impact factor: 14.307

10.  Inhibitory effect of injection of Corynebacterium parvum on the growth of tumour transplants in isogenic hosts.

Authors:  M F Woodruff; J L Boak
Journal:  Br J Cancer       Date:  1966-06       Impact factor: 7.640

View more
  63 in total

1.  Transplantation of fetal liver cells in the treatment of severe combined immunodeficiency disease.

Authors:  B Löwenberg; J M Vossen; L J Dooren
Journal:  Blut       Date:  1977-03

2.  Evidence for differentiation of NK1+ cells into cytotoxic T cells during acute rejection of allogeneic bone marrow grafts.

Authors:  G Dennert; C Knobloch; S Sugawara; B Yankelevich
Journal:  Immunogenetics       Date:  1990       Impact factor: 2.846

Review 3.  Regulation of natural killer cell function: a role for the NK cell's own MHC class I molecules.

Authors:  Werner Held; Anick Chalifour; Jérôme D Coudert
Journal:  Med Microbiol Immunol       Date:  2005-01-20       Impact factor: 3.402

Review 4.  Cis interactions of immunoreceptors with MHC and non-MHC ligands.

Authors:  Werner Held; Roy A Mariuzza
Journal:  Nat Rev Immunol       Date:  2008-02-29       Impact factor: 53.106

5.  Combination therapy using IL-2 and anti-CD25 results in augmented natural killer cell-mediated antitumor responses.

Authors:  William H D Hallett; Erik Ames; Maite Álvarez; Isabel Barao; Patricia A Taylor; Bruce R Blazar; William J Murphy
Journal:  Biol Blood Marrow Transplant       Date:  2008-10       Impact factor: 5.742

6.  Bone Marrow Cell Rejection, MHC, NK Cells, and Missing Self Recognition: Ain't That Peculiar (with Apologies to Marvin Gaye).

Authors:  David H Raulet
Journal:  J Immunol       Date:  2015-10-01       Impact factor: 5.422

7.  A genetic analysis of natural resistance to nonsyngeneic cells: the role of H-2.

Authors:  G A Carlson; B A Taylor; S T Marshall; A H Greenberg
Journal:  Immunogenetics       Date:  1984       Impact factor: 2.846

8.  Casein-induced experimental amyloidosis. IX. Alterations in marrow dependent function.

Authors:  D Yonkosky; V Kumar; E S Cathcart; M Bennett
Journal:  Immunology       Date:  1978-07       Impact factor: 7.397

9.  Suppression of H-2b-associated resistance to Friend erythroleukemia virus by a class I gene from the H-2d major histocompatibility complex haplotype.

Authors:  D Polsky; F Lilly
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-15       Impact factor: 11.205

10.  Clonal analysis of the T lymphocytes involved in parent versus F1 graft-versus-host reaction.

Authors:  P F Piguet
Journal:  Immunogenetics       Date:  1984       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.